Download Files:
JAK-IN-17
SKU
HY-144057-Get quote
Category Reference compound
Tags Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt, Inflammation/Immunology, JAK
Products Details
Product Description
– JAK-IN-17 is a potent inhibitor of JAK. JAK-IN-17 is useful for the research of multiple diseases, particularly ocular, skin, and respiratory diseases (extracted from patent WO2021185305A1, compound 9-1)[1].
Web ID
– HY-144057
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C33H38F2N6O8
References
– [1]Zhang Chen, et al. An indazole derivative and its application in medicine. Patent WO2021185305A1.
Molecular Weight
– 684.69
SMILES
– CC([C@@H]([C@H](C(O)=O)O)O)=O.CCC1=CC(O)=C(C=C1C2=CC(F)=C3C(NN=C3C4=NC5=C(N4)CCN(C5)C(CN6CCO[C@H](C6)C)=O)=C2)F
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– JAK
Pathway
– Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.